PDE4B gene polymorphism in Russian patients with panic disorder.
Alena V Malakhova1, Olga I Rudko1, Vladimir V Sobolev2,3,4
1Lomonosov Moscow State University, Faculty of Biology, Moscow, Russia.
AIMS Genetics
|October 31, 2019
Summary
Two specific PDE4B gene complex genotypes show a protective association with panic disorder, suggesting a role in mitigating genetic predisposition to the condition.
Area of Science:
- Genetics
- Psychiatry
- Molecular Biology
Background:
- Panic disorder has a complex etiology with a known genetic component.
- The PDE4B gene regulates cyclic adenosine monophosphate (cAMP) levels, impacting cellular processes.
- PDE4B gene polymorphisms have been linked to various mental health disorders, including panic disorder.
Purpose of the Study:
- To investigate the association between three single nucleotide polymorphisms (SNPs) in the PDE4B gene and the development of panic disorder.
- To evaluate the role of PDE4B gene variations in panic disorder susceptibility.
Main Methods:
- Study included 94 patients diagnosed with panic disorder (DSM-IV criteria) and 192 healthy controls.
- Genotyping of PDE4B gene SNPs was performed using real-time polymerase chain reaction (PCR) with TaqMan probes.
Main Results:
- No significant association was found between individual PDE4B SNPs and panic disorder in the general or sex-specific cohorts.
- Two complex genotypes (combinations of SNPs) in the PDE4B gene demonstrated a protective association with panic disorder, irrespective of gender.
- These protective genotypes did not show correlation with patient sex.
Conclusions:
- Two complex genotypes within the PDE4B gene are associated with a reduced risk of panic disorder.
- This suggests that PDE4B gene polymorphisms may modulate the effect of other predisposing genes in panic disorder development.
- Further research is warranted to elucidate the precise mechanisms underlying this protective effect.
Related Concept Videos
Panic Disorder
542
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
542
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
587
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
587
Human Genetics
1.3K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.3K
Single Nucleotide Polymorphisms-SNPs
17.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.8K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
508
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
508
G-protein Coupled Receptors
131.3K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.3K


